trending Market Intelligence /marketintelligence/en/news-insights/trending/ORwDLTrltv6tShBbfR7_Hg2 content esgSubNav
In This List

HPC Biosciences fiscal H1 profit climbs 52.3% YOY

Podcast

Next in Tech | Episode 50: InfoSec spending up, again…

Blog

Broadcast deal market recap 2021

Podcast

Next in Tech | Episode 49: Carbon reduction in cloud

Blog

Price wars in India: Disney+ Hotstar vs. Amazon Prime Video vs. Netflix


HPC Biosciences fiscal H1 profit climbs 52.3% YOY

HPC Biosciences Ltd. said its normalized net income for the fiscal first half ended Sept. 30 amounted to 2 Indian paise per share, an increase of 49.0% from 1 paise per share in the year-earlier period.

Normalized net income, which excludes unusual gains or losses on a pre- and after-tax basis, was 2.9 million rupees, a gain of 52.3% from 1.9 million rupees in the prior-year period.

Total revenue rose 68.2% on an annual basis to 14.5 million rupees from 8.6 million rupees, and total operating expenses increased 63.7% from the prior-year period to 9.8 million rupees from 6.0 million rupees.

Reported net income rose 50.7% from the prior-year period to 4.5 million rupees, or 3 paise per share, from 3.0 million rupees, or 2 paise per share.

As of Dec. 1, US$1 was equivalent to 61.95 Indian rupees.